Gilead Sciences (GILD) Tops Q1 EPS by 48c, Raises FY Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
Go back to Gilead Sciences (GILD) Tops Q1 EPS by 48c, Raises FY Revenue Guidance
May 1, 2015 7:10 AM EDT
Piper Jaffray analyst Joshua Schimmer reiterated an Overweight rating and lifted his price target on Gilead Sciences (NASDAQ: GILD) to $120.00 (from $116.00) after the company "crushed" the quarter and raised its outlook.
Schimmer commented, "GILD hosted the 1Q earnings call after the... More
May 1, 2015 7:00 AM EDT
BMO Capital analyst Jim Birchenough reiterated an Outperform rating and $159 price target on Gilead Sciences (NASDAQ: GILD) following "strong" Q1 results after the close with room to expand in HCV.
Birchenough commented, "We are maintaining our Outperform rating on the shares of GILD... More
May 1, 2015 6:42 AM EDT
Baird analyst Brian Skorney reiterated an Outperform rating and $126 price target on Gilead Sciences (NASDAQ: GILD) following 'beat and raise' Q1.
Skorney commented, "A sizeable beat should be enough to support the stock and perhaps stop the sector slide. We expect... More
April 30, 2015 5:21 PM EDT
Gilead Sciences (NASDAQ: GILD) declared a quarterly dividend of $0.43 per share, or $1.72 annualized.
The dividend will be payable on June 29, 2015, to stockholders of record on June 16, 2015, with an ex-dividend date of June 12, 2015.
The annual yield on the dividend is 1.7... More
